Clinical Trial

Kaiser Colorado Flu Nudge

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Influenza infection leads to significant morbidity and mortality each year. Influenza vaccines can reduce the risk of flu and the severity of flu illness, In addition, flu vaccinations can reduce flu complications such as pneumonia or worsening of chronic heart or lung disease. Each year, Kaiser Permanente of Colorado offers influenza vaccines to patients at no cost either at primary care clinic appointments or flu walk-in clinics in the fall prior to the upcoming flu season. In addition, as part of clinic appointment reminder text messages, there is a message to get the flu vaccine for patients who have not received the vaccine prior to the clinic visit. Building on these flu reminder text messages for patients who have not received a flu vaccine, this study will test different behavioral nudge text messages to improve influenza vaccination rates.
Trial Details
NCT Number NCT07372950
Lead Sponsor Kaiser Permanente
Conditions Influenza, Vaccination
Enrollment 100,000 participants
Start Date 2025-10-06
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-28